Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07360899
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT07360899
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Serbia
- Registry status
- Recruiting
Technical summary
Registry record NCT07360899. Allocation not applicable; no masking; primary purpose treatment. Start 2025-12-01 (actual); primary completion 2026-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture
- Acronym
- ATRI-LASH
- Condition
- ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION
- Condition
- Atrial Fibrillation (AF)
- Condition
- Mitral Valve Surgery
- Condition
- Stroke (in Patients With Atrial Fibrillation)
- Condition
- Anticoagulant Therapy
- Intervention (Device)
- LAA closure using the AtriLASH
- Lead sponsor
- Institute of Cardiovascular Diseases, Vojvodina
- Collaborator
- Institute for Cardiovascular Diseases Dedinje
- Collaborator
- KBC Rebro Zagreb
- Collaborator
- Clinical Centre of Serbia
Record details
- Record id
cardio:ct-nct07360899- Content hash
92020dc7456edc5d9a94d9380eafe4a011191f892d6646f7524b27b56931eeba